Monaco Asset Management SAM Buys New Position in Schrödinger, Inc. (NASDAQ:SDGR)

Monaco Asset Management SAM acquired a new position in shares of Schrödinger, Inc. (NASDAQ:SDGR - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 80,000 shares of the company's stock, valued at approximately $1,543,000. Monaco Asset Management SAM owned about 0.11% of Schrödinger as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Avanza Fonder AB acquired a new position in Schrödinger during the fourth quarter worth $577,000. Barclays PLC raised its position in Schrödinger by 421.6% in the third quarter. Barclays PLC now owns 107,554 shares of the company's stock valued at $1,995,000 after purchasing an additional 86,933 shares during the period. State Street Corp raised its position in Schrödinger by 1.8% in the third quarter. State Street Corp now owns 2,155,620 shares of the company's stock valued at $39,987,000 after purchasing an additional 38,972 shares during the period. Quest Partners LLC raised its position in Schrödinger by 861.0% in the third quarter. Quest Partners LLC now owns 43,773 shares of the company's stock valued at $812,000 after purchasing an additional 39,218 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. raised its position in Schrödinger by 1.4% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,191,054 shares of the company's stock valued at $40,644,000 after purchasing an additional 29,920 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

A number of research firms have commented on SDGR. Piper Sandler reduced their target price on Schrödinger from $50.00 to $45.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. KeyCorp lifted their target price on Schrödinger from $25.00 to $27.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Schrödinger has a consensus rating of "Buy" and an average target price of $32.29.

Insider Buying and Selling

In other news, CFO Geoffrey Craig Porges sold 5,491 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $21.76, for a total transaction of $119,484.16. Following the completion of the transaction, the chief financial officer now directly owns 27,544 shares of the company's stock, valued at approximately $599,357.44. This represents a 16.62 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 8.60% of the stock is currently owned by insiders.

Schrödinger Trading Down 3.5 %

SDGR traded down $0.83 on Tuesday, hitting $22.90. 1,075,241 shares of the company were exchanged, compared to its average volume of 747,115. Schrödinger, Inc. has a twelve month low of $16.67 and a twelve month high of $29.15. The company has a market cap of $1.67 billion, a price-to-earnings ratio of -9.79 and a beta of 1.62. The firm has a 50-day moving average price of $22.75 and a two-hundred day moving average price of $20.72.

Schrödinger (NASDAQ:SDGR - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported ($0.55) EPS for the quarter, missing the consensus estimate of ($0.35) by ($0.20). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The company had revenue of $88.32 million for the quarter, compared to analyst estimates of $83.20 million. Equities analysts expect that Schrödinger, Inc. will post -2.37 EPS for the current year.

Schrödinger Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.